Inventiva SA (IVA) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

IVA is expected to report earnings to fall 43.42% to -43 cents per share on March 26

Q4'24

Est.

$-0.43

Q3'24

Missed

by $0.20

Q2'24

Missed

by $0.17

Q1'24

Beat

by $0.04

Q4'23

Beat

by $0.04

The last earnings report on November 21 showed earnings per share of -75 cents, missing the estimate of -56 cents. With 22.77K shares outstanding, the current market capitalization sits at 118.15M.

View a ticker or compare two or three

Compare

IVA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IVA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

50 rue de Dijon

Phone

+33 380447500

Employees

123

Web

https://www.inventivapharma.com